An Introduction to Clinical Study Start Up [Video]

Clinical study start-up is the phase where a clinical trial moves from planning towards first patient enrolment. This video explains how feasibility, budgets, contracts, ethics and regulatory submissions, and site readiness all affect whether sites can be authorised and operationally ready to enrol.

WHAT THIS VIDEO COVERS
• The difference between clinical study start-up and site start-up
• How feasibility tests whether the protocol can run at proposed sites
• Why operational burden can change site readiness
• How budgets, contracts, ethics review, and regulatory submissions can delay activation
• Where waiting time and handoffs affect start-up timelines
• Why ownership, parallel workstreams, and measurement matter during start-up

Start-up is easier to manage when teams can see which delays are unavoidable and which are caused by gaps in the workflow. Clear dependencies, defined ownership, and measured cycle times can help reduce hidden operational risk before enrolment begins.

Quanticate combines experienced biometrics and clinical operations teams with inspection-ready data solutions to support efficient, well-controlled clinical study start up. If you would like support with feasibility planning, start up strategy, data management, statistics, or programming for your next trial, please request a consultation and a member of our team will be in touch.